Plasma amino acids changes in complex regional pain syndrome

Pain Research and Treatment

Volumn 2013, Issue , 2013, Pages

  Alexander, Guillermo M ^a   Reichenberger, Erin ^a   Peterlin, B Lee ^b   Perreault, Marielle J ^a   Grothusen, John R ^a   Schwartzman, Robert J ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84888883263     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2013/742407     Document Type: Article

References (83)

1. Jänig W., Baron R., Complex regional pain syndrome: mystery explained? The Lancet Neurology 2003 2 11 687 697 2-s2.0-0142157604 10.1016/S1474-4422(03)00557-X (Pubitemid 37311322)
2. Schwartzman R. J., Alexander G. M., Grothusen J., Pathophysiology of complex regional pain syndrome. Expert Review of Neurotherapeutics 2006 6 5 669 681 2-s2.0-33745113527 10.1586/14737175.6.5.669 (Pubitemid 43964715)
3. Schwartzman R. J., Erwin K. L., Alexander G. M., The natural history of complex regional pain syndrome. Clinical Journal of Pain 2009 25 4 273 280 2-s2.0-67649553641 10.1097/AJP.0b013e31818ecea5
4. Harden R. N., Bruehl S., Stanton-Hicks M., Wilson P. R., Proposed new diagnostic criteria for complex regional pain syndrome. Pain Medicine 2007 8 4 326 331 2-s2.0-34447292383 10.1111/j.1526-4637.2006.00169.x (Pubitemid 47039415)
5. Loeser J. D., Bonica's the Management of Pain 2001 3rd Philadelphia, Pa, USA Lippincott Williams, & Wilkins
6. Plewes L. W., Sudek's atrophy in the hands. The Journal of Bone & Joint Surgery 1956 38 195 203
7. Bickerstaff D. R., Kanis J. A., Algodystrophy: an under-recognized complication of minor trauma. British Journal of Rheumatology 1994 33 3 240 248 2-s2.0-0028221048 (Pubitemid 24089774)
8. Sandroni P., Benrud-Larson L. M., McClelland R. L., Low P. A., Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 2003 103 1-2 199 207 2-s2.0-0038243549 10.1016/S0304-3959(03)00065-4 (Pubitemid 36579099)
9. Costigan M., Scholz J., Woolf C. J., Neuropathic pain: a maladaptive response of the nervous system to damage. Annual Review of Neuroscience 2009 32 1 32 2-s2.0-67651048942 10.1146/annurev.neuro.051508.135531
10. Watkins L. R., Maier S. F., Immune regulation of central nervous system functions: from sickness responses to pathological pain. Journal of Internal Medicine 2005 257 2 139 155 2-s2.0-13244281729 10.1111/j.1365-2796.2004.01443.x (Pubitemid 40193964)
11. Woolf C. J., Salter M. W., Neuronal plasticity: increasing the gain in pain. Science 2000 288 5472 1765 1768 2-s2.0-0034625770 10.1126/science.288. 5472.1765 (Pubitemid 30399008)
12. Austin P. J., Moalem-Taylor G., The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. Journal of Neuroimmunology 2010 229 1-2 26 50 2-s2.0-78650309320 10.1016/j.jneuroim.2010.08.013
13. Costigan M., Moss A., Latremoliere A., Johnston C., Verma-Gandhu M., Herbert T. A., Barrett L., Brenner G. J., Vardeh D., Woolf C. J., Fitzgerald M., T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. Journal of Neuroscience 2009 29 46 14415 14422 2-s2.0-70949108323 10.1523/JNEUROSCI.4569-09.2009
14. del Valle L., Schwartzman R. J., Alexander G., Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome. Brain, Behavior, and Immunity 2009 23 1 85 91 2-s2.0-56949106793 10.1016/j.bbi.2008.08.004
15. Goebel A., Blaes F., Complex regional pain syndrome, prototype of a novel kind of autoimmune disease. Autoimmunity Reviews 2013 12 6 682 686
16. Watkins L. R., Maier S. F., Glia: a novel drug discovery target for clinical pain. Nature Reviews Drug Discovery 2003 2 12 973 985 2-s2.0-0347169249 (Pubitemid 37540579)
17. Marchand F., Perretti M., McMahon S. B., Role of the immune system in chronic pain. Nature Reviews Neuroscience 2005 6 7 521 532 2-s2.0-21744433587 10.1038/nrn1700 (Pubitemid 40942819)
18. McMahon S. B., Cafferty W. B. J., Marchand F., Immune and glial cell factors as pain mediators and modulators. Experimental Neurology 2005 192 2 444 462 2-s2.0-14844303420 10.1016/j.expneurol.2004.11.001 (Pubitemid 40341688)
19. Abbadie C., Chemokines, chemokine receptors and pain. Trends in Immunology 2005 26 10 529 534 2-s2.0-24744468023 10.1016/j.it.2005.08.001 (Pubitemid 41297683)
20. DeLeo J. A., Colburn R. W., Nichols M., Malhotra A., Interleukin-6- mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. Journal of Interferon and Cytokine Research 1996 16 9 695 700 2-s2.0-0029783630 (Pubitemid 26330415)
21. Tsuda M., Inoue K., Salter M. W., Neuropathic pain and spinal microglia: a big problem from molecules in 'small' glia. Trends in Neurosciences 2005 28 2 101 107 2-s2.0-13144276331 10.1016/j.tins.2004.12.002 (Pubitemid 40178927)
22. Kreutzberg G. W., Microglia: a sensor for pathological events in the CNS. Trends in Neurosciences 1996 19 8 312 318 2-s2.0-0030222037 10.1016/0166-2236(96)10049-7 (Pubitemid 26349059)
23. Watkins L. R., Milligan E. D., Maier S. F., Glial activation: a driving force for pathological pain. Trends in Neurosciences 2001 24 8 450 455 2-s2.0-0035426434 10.1016/S0166-2236(00)01854-3 (Pubitemid 32695356)
24. Alexander G. M., van Rijn M. A., van Hilten J. J., Perreault M. J., Schwartzman R. J., Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 2005 116 3 213 219 2-s2.0-21844454740 10.1016/j.pain.2005.04.013 (Pubitemid 40957124)
25. Alexander G. M., Perreault M. J., Reichenberger E. R., Schwartzman R. J., Changes in immune and glial markers in the CSF of patients with complex regional pain syndrome. Brain, Behavior, and Immunity 2007 21 5 668 676 2-s2.0-34249658983 10.1016/j.bbi.2006.10.009 (Pubitemid 46829771)
26. Alexander G. M., Peterlin B. L., Perreault M. J., Grothusen J. R., Schwartzman R. J., Changes in plasma cytokines and their soluble receptors in complex regional pain syndrome. Journal of Pain 2012 13 1 10 20 2-s2.0-84855256950 10.1016/j.jpain.2011.10.003
27. Huygen F. J. P. M., de Bruijn A. G. J., de Bruin M. T., George Groeneweg J., Klein J., Zijlstra F. J., Evidence for local inflammation in complex regional pain syndrome type 1. Mediators of Inflammation 2002 11 1 47 51 2-s2.0-0036200129 10.1080/09629350210307 (Pubitemid 34252547)
28. Arima Y., Harada M., Kamimura D., Park J.-H., Kawano F., Yull F. E., Kawamoto T., Iwakura Y., Betz U. A. K., Márquez G., Blackwell T. S., Ohira Y., Hirano T., Murakami M., Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 2012 148 3 447 457 2-s2.0-84856726089 10.1016/j.cell.2012.01.022
29. Echeverry S., Shi X. Q., Rivest S., Zhang J., Peripheral nerve injury alters blood-spinal cord barrier functional and molecular integrity through a selective inflammatory pathway. Journal of Neuroscience 2011 31 30 10819 10828 2-s2.0-79960941570 10.1523/JNEUROSCI.1642-11.2011
30. Bronte V., Zanovello P., Regulation of immune responses by L-arginine metabolism. Nature Reviews Immunology 2005 5 8 641 654 2-s2.0-23444456772 10.1038/nri1668 (Pubitemid 41113195)
31. Grohmann U., Fallarino F., Puccetti P., Tolerance, DCs and tryptophan: much ado about IDO. Trends in Immunology 2003 24 5 242 248 2-s2.0-0038215374 10.1016/S1471-4906(03)00072-3 (Pubitemid 36555962)
32. Hwang S. L., Chung N. P.-Y., Chan J. K.-Y., Lin C.-L. S., Indoleamine 2,3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines. Cell Research 2005 15 3 167 175 2-s2.0-27844576217 10.1038/sj.cr.7290282 (Pubitemid 41653939)
33. Ploder M., Spittler A., Kurz K., Neurauter G., Pelinka L. E., Roth E., Fuchs D., Accelerated tryptophan degradation predicts poor survival in trauma and sepsis patients. International Journal of Tryptophan Research 2010 3 1 61 67 2-s2.0-84859877054
34. Morris S. M. Jr., Arginases and arginine deficiency syndromes. Current Opinion in Clinical Nutrition & Metabolic Care 2012 15 64 70
35. Schmidtko A., Tegeder I., Geisslinger G., No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing. Trends in Neurosciences 2009 32 6 339 346 2-s2.0-66249111509 10.1016/j.tins.2009.01.010
36. Bazzichi L., Palego L., Giannaccini G., Rossi A., De Feo F., Giacomelli C., Betti L., Giusti L., Mascia G., Bombardieri S., Lucacchini A., Altered amino acid homeostasis in subjects affected by fibromyalgia. Clinical Biochemistry 2009 42 10-11 1064 1070 2-s2.0-67349225276 10.1016/j.clinbiochem.2009.02.025
37. Moldofsky H., Warsh J. J., Plasma tryptophan and musculoskeletal pain in non-articular rheumatism ("fibrositis syndrome"). Pain 1978 5 1 65 71 2-s2.0-0018193373 10.1016/0304-3959(78)90025-8 (Pubitemid 8358135)
38. Wesseldijk F., Fekkes D., Huygen F. J. P. M., van de Heide-Mulder M., Zijlstra F. J., Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type 1. Acta Anaesthesiologica Scandinavica 2008 52 5 688 694 2-s2.0-42249098850 10.1111/j.1399-6576.2008.01638.x (Pubitemid 351549580)
39. Yunus N. B., Dailey J. W., Aldag J. C., Masi A. T., Jobe P. C., Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. Journal of Rheumatology 1992 19 1 90 94 2-s2.0-0026503839
40. Snyder S. H., Ferris C. D., Novel neurotransmitters and their neuropsychiatric relevance. The American Journal of Psychiatry 2000 157 11 1738 1751 2-s2.0-0033765902 10.1176/appi.ajp.157.11.1738
41. Wolosker H., D-serine regulation of NMDA receptor activity. Science's STKE 2006 2006 356 pe41 2-s2.0-33750585899 10.1126/stke.3562006pe41
42. 2+ current. Neuron 2007 53 1 17 24 2-s2.0-33845710812 10.1016/j.neuron.2006.11.016 (Pubitemid 44969487)
43. Zito K., Scheuss V., Knott G., Hill T., Svoboda K., Rapid functional maturation of nascent dendritic spines. Neuron 2009 61 2 247 258 2-s2.0-58849093289 10.1016/j.neuron.2008.10.054
44. Jang J. H., Kim D.-W., Sang Nam T., Se Paik K., Leem J. W., Peripheral glutamate receptors contribute to mechanical hyperalgesia in a neuropathic pain model of the rat. Neuroscience 2004 128 1 169 176 2-s2.0-4344582137 10.1016/j.neuroscience.2004.06.040 (Pubitemid 39140690)
45. Boldyrev A. A., Bryushkova E. A., Vladychenskaya E. A., NMDA receptors in immune competent cells. Biochemistry 2012 77 2 128 134 2-s2.0-84858047238 10.1134/S0006297912020022
46. Mashkina A. P., Cizkova D., Vanicky I., Boldyrev A. A., NMDA receptors are expressed in lymphocytes activated both in vitro and in vivo. Cellular and Molecular Neurobiology 2010 30 6 901 907 2-s2.0-77956187507 10.1007/s10571-010- 9519-7
47. Schröcksnadel K., Wirleitner B., Winkler C., Fuchs D., Monitoring tryptophan metabolism in chronic immune activation. Clinica Chimica Acta 2006 364 1-2 82 90 2-s2.0-31044446342 10.1016/j.cca.2005.06.013 (Pubitemid 43120630)
48. Kim H., Chen L., Lim G., Sung B., Wang S., McCabe M. F., Rusanescu G., Yang L., Tian Y., Mao J., Brain indoleamine 2, 3-dioxygenase contributes to the comorbidity of pain and depression. Journal of Clinical Investigation 2012 122 2940 2954
49. Harden R. N., Bruehl S., Perez R. S. G. M., Birklein F., Marinus J., Maihofner C., Lubenow T., Buvanendran A., MacKey S., Graciosa J., Mogilevski M., Ramsden C., Chont M., Vatine J.-J., Validation of proposed diagnostic criteria (the "Budapest Criteria") for complex regional pain syndrome. Pain 2010 150 2 268 274 2-s2.0-77955303527 10.1016/j.pain.2010.04.030
50. Grothusen J. R., Alexander G. M., Erwin K., Schwartzman R. J., Thermal pain in complex regional pain syndrome type I. Pain Physician. In press
51. Hashimoto A., Nishikawa T., Oka T., Takahashi K., Hayashi T., Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N- tert.-butyloxycarbonyl-L-cysteine and o -phthaldialdehyde. Journal of Chromatography B 1992 582 1-2 41 48 2-s2.0-0026455011 10.1016/0378-4347(92) 80300-F
52. Maneglier B., Rogez-Kreuz C., Cordonnier P., Therond P., Advenier C., Dormont D., Clayette P., Spreux-Varoquaux O., Simultaneous measurement of kynurenine and tryptophan in human plasma and supernatants of cultured human cells by HPLC with coulometric detection. Clinical Chemistry 2004 50 11 2166 2168 2-s2.0-7044246030 10.1373/clinchem.2004.037465 (Pubitemid 39425862)
53. Sharma A., Agarwal S., Broatch J., Raja S. N., A web-based cross-sectional epidemiological survey of complex regional pain syndrome. Regional Anesthesia and Pain Medicine 2009 34 2 110 115 2-s2.0-62949150576 10.1097/AAP.0b013e3181958f90
54. Yarnitsky D., Sprecher E., Thermal testing: normative data and repeatability for various test algorithms. Journal of the Neurological Sciences 1994 125 1 39 45 2-s2.0-0027992449 10.1016/0022-510X(94)90239-9 (Pubitemid 24240185)
55. Wasner G. L., Brock J. A., Determinants of thermal pain thresholds in normal subjects. Clinical Neurophysiology 2008 119 10 2389 2395 2-s2.0-50849133983 10.1016/j.clinph.2008.07.223
56. Yarnitsky D., Sprecher E., Zaslansky R., Hemli J. A., Heat pain thresholds: normative data and repeatability. Pain 1995 60 3 329 332 2-s2.0-0028950766 10.1016/0304-3959(94)00132-X
57. Murr C., Gerlach D., Widner B., Dierich M. P., Fuchs D., Neopterin production and tryptophan degradation in humans infected by Streptococcus pyogenes. Medical Microbiology and Immunology 2001 189 3 161 163 2-s2.0-0034451873 10.1007/s430-001-8023-3 (Pubitemid 33726402)
58. Grahame-Smith D. G., The biosynthesis of 5-hydroxytryptamine in brain. Biochemical Journal 1967 105 1 351 360 2-s2.0-0014144506
59. Fuchs D., Möller A. A., Reibnegger G., Stöckle E., Werner E. R., Wachter H., Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. Journal of Acquired Immune Deficiency Syndromes 1990 3 9 873 876 2-s2.0-0024994054 (Pubitemid 20330669)
60. Bell C., Abrams J., Nutt D., Tryptophan depletion and its implications for psychiatry. British Journal of Psychiatry 2001 178 399 405 2-s2.0-0035021701 10.1192/bjp.178.5.399 (Pubitemid 32436803)
61. Bronte V., Serafini P., Mazzoni A., Segal D. M., Zanovello P., L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends in Immunology 2003 24 6 302 306 2-s2.0-0041966165
62. Windmueller H. G., Spaeth A. E., Source and fate of circulating citrulline. The American Journal of Physiology-Endocrinology and Metabolism 1981 241 6 E473 E480 2-s2.0-0019750437
63. Bogdan C., Nitric oxide and the immune response. Nature Immunology 2001 2 10 907 916 2-s2.0-0034769118 10.1038/ni1001-907 (Pubitemid 32976162)
64. Wu G., Morris S. M. Jr., Arginine metabolism: nitric oxide and beyond. Biochemical Journal 1998 336 1 1 17 2-s2.0-0032533159 (Pubitemid 28532555)
65. Levy D., Zochodne D. W., NO pain: potential roles of nitric oxide in neuropathic pain. Pain Practice 2004 4 11 18
66. Luo Z. D., Cizkova D., The role of nitric oxide in nociception. Current Review of Pain 2000 4 6 459 466 2-s2.0-0033660663
67. Meller S. T., Gebhart G. F., Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993 52 2 127 136 2-s2.0-0027502194 10.1016/0304-3959(93)90124-8 (Pubitemid 23068181)
68. Haley J. E., Dickenson A. H., Schachter M., Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992 31 3 251 258 2-s2.0-0026590985 10.1016/0028-3908(92) 90175-O
69. Zhuo M., Meller S. T., Gebhart G. F., Endogenous nitric oxide is required for tonic cholinergic inhibition of spinal mechanical transmission. Pain 1993 54 1 71 78 2-s2.0-0027253732 10.1016/0304-3959(93)90101-T (Pubitemid 23200573)
70. Shimmura C., Suda S., Tsuchiya K. J., Hashimoto K., Ohno K., Matsuzaki H., Iwata K., Matsumoto K., Wakuda T., Kameno Y., Suzuki K., Tsujii M., Nakamura K., Takei N., Mori N., Alteration of plasma glutamate and glutamine levels in children with high-functioning autism. PLoS ONE 2011 6 10 2-s2.0-80053593781 10.1371/journal.pone.0025340 e25340
71. Sheldon A. L., Robinson M. B., The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochemistry International 2007 51 6-7 333 355 2-s2.0-34848842158 10.1016/j.neuint.2007.03.012 (Pubitemid 47503456)
72. Reeds P. J., Burrin D. G., Stoll B., Jahoor F., Intestinal glutamate metabolism. Journal of Nutrition 2000 130 4, supplemet 978S 982S 2-s2.0-0034020451 (Pubitemid 30173628)
73. Smith Q. R., Transport of glutamate and other amino acids at the blood-brain barrier. Journal of Nutrition 2000 130 4, supplement 1016S 1022S 2-s2.0-0034098766 (Pubitemid 30173636)
74. Julio-Pieper M., Flor P. J., Dinan T. G., Cryan J. F., Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacological Reviews 2011 63 1 35 58 2-s2.0-79952021183 10.1124/pr.110.004036
75. Karim F., Bhave G., Gereau R. W. IV, Metabotropic glutamate receptors on peripheral sensory neuron terminals as targets for the development of novel analgesics. Molecular Psychiatry 2001 6 6 615 617 2-s2.0-0034749799 10.1038/sj.mp.4000961 (Pubitemid 33020578)
76. Lalo U., Pankratov Y., Kirchhoff F., North R. A., Verkhratsky A., NMDA receptors mediate neuron-to-glia signaling in mouse cortical astrocytes. Journal of Neuroscience 2006 26 10 2673 2683 2-s2.0-33644826773 10.1523/JNEUROSCI.4689- 05.2006 (Pubitemid 43357850)
77. Verkhratsky A., Kirchhoff F., NMDA receptors in glia. Neuroscientist 2007 13 1 28 37 2-s2.0-33846025401 10.1177/1073858406294270 (Pubitemid 46052751)
78. Makhro A., Wang J., Vogel J., Boldyrev A. A., Gassmann M., Kaestner L., Bogdanova A., Functional NMDA receptors in rat erythrocytes. The American Journal of Physiology-Cell Physiology 2010 298 6 C1315 C1325 2-s2.0-77952600362 10.1152/ajpcell.00407.2009
79. Sharp C. D., Fowler M., Jackson T. H. IV, Houghton J., Warren A., Nanda A., Chandler I., Cappell B., Long A., Minagar A., Alexander J. S., Human neuroepithelial cells express NMDA receptors. BMC Neuroscience 2003 4, article 28 2-s2.0-2642574368 10.1186/1471-2202-4-28 (Pubitemid 38729152)
80. Correll G. E., Maleki J., Gracely E. J., Muir J. J., Harbut R. E., Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Medicine 2004 5 3 263 275 2-s2.0-5644250895 10.1111/j.1526-4637.2004.04043.x (Pubitemid 39369246)
81. Kiefer R. T., Rohr P., Ploppa A., Dieterich H.-J., Grothusen J., Koffler S., Altemeyer K.-H., Unertl K., Schwartzman R. J., Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Medicine 2008 9 8 1173 1201 2-s2.0-56449113666 10.1111/j.1526-4637.2007.00402.x
82. Schwartzman R. J., Alexander G. M., Grothusen J. R., Paylor T., Reichenberger E., Perreault M., Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain 2009 147 1-3 107 115 2-s2.0-70450223904 10.1016/j.pain.2009.08.015
83. Sigtermans M. J., van Hilten J. J., Bauer M. C. R., Arbous M. S., Marinus J., Sarton E. Y., Dahan A., Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain 2009 145 3 304 311 2-s2.0-69649087572 10.1016/j.pain.2009.06.023